Marshall Wace’s Medicines Co MDCO Stock Holding History

Marshall Wace’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-71,945	Closed	-$6.11M	–	2286
2019 Q4	$6.11M	Sell	71,945 -554,217	-89%	-$37M	0.04%	460
2019 Q3	$31.3M	Buy	+626,162	New	+$25M	0.25%	88
2017 Q1	–	Sell	-283,622	Closed	-$9.63M	–	889
2016 Q4	$9.63M	Buy	+283,622	New	+$10.1M	0.06%	346
2016 Q1	–	Sell	-125,253	Closed	-$4.68M	–	1263
2015 Q4	$4.68M	Buy	+125,253	New	+$4.73M	0.04%	395
2015 Q2	–	Sell	-420,096	Closed	-$11.8M	–	1111
2015 Q1	$11.8M	Buy	420,096 +373,870	+809%	+$10.5M	0.15%	169
2014 Q4	$1.28M	Buy	+46,226	New	+$1.15M	0.02%	536

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Marshall Wace's MDCO Position: Q1 2020 in Review

Marshall Wace sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 71,945 shares — an estimated $6.11M sold.

Marshall Wace first reported a position in MDCO in Q4 2014 and held it in 6 quarters. The position peaked at $31.3M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Marshall Wace reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Marshall Wace sold 71,945 Medicines Co shares in Q1 2020, an estimated $6.11M.
Marshall Wace first reported a position in Medicines Co in Q4 2014 and held it in 6 quarters.
Marshall Wace's Medicines Co position peaked at $31.3M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.